Mediera Corporation (TPEX:5398)
Taiwan · Delayed Price · Currency is TWD 22.40
-0.60 (-2.61%)
Jan 22, 2026, 1:30 PM CST
Mediera Market Cap
Mediera has a market cap or net worth of 1.14 billion as of January 22, 2026. Its market cap has increased by 10.05% in one year.
Market Cap
1.14B
Enterprise Value
1.04B
Revenue
240.30M
Ranking
n/a
PE Ratio
82.14
Stock Price
22.40
Market Cap Chart
Since November 3, 2004, Mediera's market cap has increased from 257.38M to 1.14B, an increase of 342.03%. That is a compound annual growth rate of 7.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 1.14B | -11.54% |
| Dec 31, 2025 | 1.29B | 33.67% |
| Dec 31, 2024 | 962.10M | 27.54% |
| Dec 29, 2023 | 754.35M | -7.01% |
| Dec 30, 2022 | 811.23M | -19.01% |
| Dec 30, 2021 | 1.00B | 4.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GeneFerm Biotechnology | 1.90B |
| InnoPharmax | 1.77B |
| Winston Medical Supply | 1.46B |
| DV Biomed | 1.43B |
| Excelsior Biopharma | 1.40B |
| Tien Liang BioTech | 1.39B |
| Prince Pharmaceutical | 1.12B |
| Anxo Pharmaceutical | 1.12B |